We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Customers Bancorp
CUBI
$2.59B
| $35.7K | ﹤0.01% |
515
+83
| +19% | +$6.03K |
|
1777
CleanSpark
CLSK
$3.73B
| $35.6K | ﹤0.01% |
4,180
+411
| +11% | +$4.4K |
|
1778
Braze
BRZE
$2.45B
| $35.5K | ﹤0.01% |
1,502
+431
| +40% | +$9.32K |
|
1779
Ceco Environmental
CECO
$4.42B
| $35.5K | ﹤0.01% |
595
+133
| +29% | +$8.56K |
|
|
OS
1780
DELISTED
OneStream Inc
OS
| $35.4K | ﹤0.01% |
1,475
+477
| +48% | +$11.2K |
|
1781
ADMA Biologics
ADMA
$1.92B
| $35.3K | ﹤0.01% |
3,923
+858
| +28% | +$13.5K |
|
1782
Intuitive Machines
LUNR
$2.07B
| $35.3K | ﹤0.01% |
1,904
+436
| +30% | +$8.04K |
|
1783
RXO
RXO
$4.23B
| $35.3K | ﹤0.01% |
2,414
+478
| +25% | +$7.01K |
|
1784
First Commonwealth Financial
FCF
$2.12B
| $35.1K | ﹤0.01% |
1,996
+490
| +33% | +$8.63K |
|
1785
RPC Inc
RES
$1.24B
| $35.1K | ﹤0.01% |
4,952
+727
| +17% | +$4.53K |
|
1786
Amalgamated Financial
AMAL
$1.48B
| $34.9K | ﹤0.01% |
899
+225
| +33% | +$8.53K |
|
1787
StepStone Group
STEP
$3.48B
| $34.5K | ﹤0.01% |
722
-58
| -7% | -$3.35K |
|
1788
Prestige Consumer Healthcare
PBH
$2.35B
| $34.4K | ﹤0.01% |
581
+77
| +15% | +$5K |
|
1789
RH
RH
$3.3B
| $34.3K | ﹤0.01% |
245
-872
| -78% | -$159K |
|
|
DFTX
1790
Definium Therapeutics
DFTX
$5.73B
| $34.2K | ﹤0.01% |
1,812
+433
| +31% | +$7.35K |
|
1791
Northwest Bancshares
NWBI
$2.25B
| $34.2K | ﹤0.01% |
2,697
+686
| +34% | +$8.63K |
|
1792
Neogen
NEOG
$2.05B
| $34.2K | ﹤0.01% |
3,679
+911
| +33% | +$8.96K |
|
1793
Horizon Bancorp
HBNC
$1.03B
| $34K | ﹤0.01% |
2,049
+567
| +38% | +$9.71K |
|
1794
Rithm Capital
RITM
$5.09B
| $33.8K | ﹤0.01% |
3,564
+53
| +2% | +$555 |
|
1795
Winmark
WINA
$1.19B
| $33.8K | ﹤0.01% |
79
+26
| +49% | +$11.5K |
|
1796
Carter's
CRI
$1.43B
| $33.3K | ﹤0.01% |
930
+256
| +38% | +$9.31K |
|
1797
Immunovant
IMVT
$8.09B
| $33.1K | ﹤0.01% |
1,333
+508
| +62% | +$13.2K |
|
1798
Enliven Therapeutics
ELVN
$3.78B
| $33.1K | ﹤0.01% |
844
+209
| +33% | +$5.79K |
|
|
NTST
1799
NETSTREIT Corp
NTST
$2.16B
| $32.8K | ﹤0.01% |
1,744
+448
| +35% | +$8.63K |
|
|
CON
1800
Concentra Group Holdings
CON
$4.04B
| $32.3K | ﹤0.01% |
1,506
+301
| +25% | +$6.7K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.